{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:58:40Z","timestamp":1790485120768,"version":"4.1.0"},"reference-count":118,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondation J\u00e9r\u00f4me Lejeune","award":["2421_GRT-2024B"],"award-info":[{"award-number":["2421_GRT-2024B"]}]},{"award":["2421_GRT-2024B"],"award-info":[{"award-number":["2421_GRT-2024B"]}],"id":[{"id":"https:\/\/ror.org\/03js3tm40","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Down syndrome (trisomy 21) is the most common genetic cause of intellectual disability. Seizures are a frequent comorbidity in individuals with Down syndrome and can exert significant negative consequences on cognitive capacity and quality of life. In Down syndrome, seizures cluster at two extremes of the lifespan. In the first year of life, infantile epileptic spasms syndrome affects 5\u201310% of children with Down syndrome. The second peak occurs after age 30 years, when myoclonic seizures appear at the time of onset of Down syndrome-related dementia of the Alzheimer type (late-onset myoclonic epilepsy in Down syndrome or LOMEDS). While epilepsy at these two disparate time points has been long recognized in the Down syndrome population, the mechanisms underlying seizure pathogenesis have not been studied in detail. For example, it is not known whether the brain developmental abnormalities that characterize Down syndrome are primarily responsible for the epilepsies or whether distinct mechanisms underlie seizures at the two ages. This narrative review addresses possible mechanisms of seizure propensity across the lifespan, with special reference to potential age-specific treatments.<\/jats:p>","DOI":"10.3390\/jcm15197471","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:34:10Z","timestamp":1790332450000},"page":"7471","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epilepsy Mechanisms in Down Syndrome: Genetic and Pathophysiological Perspectives Across the Lifespan"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4432-2453","authenticated-orcid":false,"given":"Carl E.","family":"Stafstrom","sequence":"first","affiliation":[{"name":"Division of Pediatric Neurology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-7122","authenticated-orcid":false,"given":"Li-Rong","family":"Shao","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1007\/s00415-020-10179-w","article-title":"Neurologic complications of Down syndrome: A systematic review","volume":"268","author":"Santoro","year":"2021","journal-title":"J. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archneur.1991.00530150088024","article-title":"Seizure disorders in Down syndrome","volume":"48","author":"Pueschel","year":"1991","journal-title":"Arch. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-54299-1.00006-6","article-title":"Neurological phenotypes for Down syndrome across the life span","volume":"197","author":"Lott","year":"2012","journal-title":"Prog. Brain Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2023.05.017","article-title":"Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients\u2019 data analysis","volume":"109","author":"Corniello","year":"2023","journal-title":"Seizure"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2011.0415","article-title":"Epilepsy in children with Down syndrome","volume":"13","author":"Arya","year":"2011","journal-title":"Epileptic Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.122.059706","article-title":"for Down Syndrome International (DSi). Cardiovascular complications of Down syndrome: Scoping review and expert consensus","volume":"147","author":"Dimopoulos","year":"2023","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pediatrneurol.2023.04.025","article-title":"Seizures in pediatric moyamoya: Risk factors and functional outcomes","volume":"145","author":"Gatti","year":"2023","journal-title":"Pediatr. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1469-8749.1991.tb05108.x","article-title":"Seizures in children with Down syndrome: Etiology, characteristics, and outcome","volume":"33","author":"Stafstrom","year":"1991","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/bies.201500004","article-title":"Neuronal hyperactivity\u2014A key defect in Alzheimer\u2019s disease?","volume":"37","author":"Busche","year":"2015","journal-title":"Bioessays"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainresbull.2020.04.009","article-title":"Epilepsy and Alzheimer\u2019s disease: Potential mechanisms for an association","volume":"160","author":"Giorgi","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref_13","first-page":"1","article-title":"The role of epileptic activity in Alzheimer\u2019s disease","volume":"39","author":"Chen","year":"2024","journal-title":"Amer. J. Alz. Dis. Other Dement."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e136525025","DOI":"10.1523\/JNEUROSCI.1365-25.2025","article-title":"Development of molecular neuropathology in Down syndrome across the lifespan","volume":"45","author":"Bhattacharyya","year":"2025","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41583-024-00866-2","article-title":"Consequences of trisomy 21 for brain development in Down syndrome","volume":"25","author":"Russo","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eaea1549","DOI":"10.1126\/science.aea1549","article-title":"Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex","volume":"392","author":"Risgaard","year":"2026","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eaea1259","DOI":"10.1126\/science.aea1259","article-title":"A single-cell multiomic analysis identifies molecular and gene-regulatory mechanisms dysregulated in developing Down syndrome neocortex","volume":"392","author":"Vuong","year":"2026","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2016.01.042","article-title":"Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination","volume":"89","author":"Kang","year":"2016","journal-title":"Neuron"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ponroy Bally, B., and Murai, K.K. (2021). Astrocytes in Down syndrome across the lifespan. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.702685"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/revneuro-2022-0067","article-title":"Brain circuit pathology in Down syndrome: From neurons to neural networks","volume":"34","author":"Bartesaghi","year":"2023","journal-title":"Rev. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e58731","DOI":"10.7554\/eLife.58731","article-title":"Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome","volume":"9","author":"Donato","year":"2020","journal-title":"eLife"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1523\/JNEUROSCI.2723-18.2019","article-title":"Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of Down syndrome","volume":"39","author":"Schulz","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pediatrneurol.2020.11.001","article-title":"Excitatory\/inhibitory synaptic ratios in polymicrogyria and Down syndrome help explain epileptogenesis in malformations","volume":"116","author":"Sarnat","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Shao, L.R., Habela, C.W., and Stafstrom, C.E. (2019). Pediatric epilepsy mechanisms: Expanding the paradigm of excitation\/inhibition imbalance. Children, 6.","DOI":"10.3390\/children6020023"},{"key":"ref_27","first-page":"1","article-title":"Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models","volume":"251","author":"Yu","year":"2020","journal-title":"Prog. Brain Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tig.2020.09.017","article-title":"All creatures great and small: New approaches for understanding Down syndrome genetics","volume":"37","author":"Moyer","year":"2021","journal-title":"Trends Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41467-025-68048-x","article-title":"Synaptic and intrinsic membrane defects disrupt early neural network dynamics in Down syndrome","volume":"17","author":"Hannan","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Brault, V., Nguyen, T.L., Flores-Gutierrez, J., Iacono, G., Birling, M.-C., Lalanne, V., Meziane, H., Manousopoulou, A., Pavlovic, G., and Lindner, L. (2021). Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome. PLoS Genet., 17.","DOI":"10.1101\/2021.05.01.442242"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2014.04.016","article-title":"Excitation\/inhibition balance and learning are modified by Dyrk1a gene dosage","volume":"69","author":"Souchet","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"dmm052740","DOI":"10.1242\/dmm.052740","article-title":"Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells","volume":"19","author":"West","year":"2026","journal-title":"Dis. Model. Mech."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mitsogiannis, M.D., Pancho, A., Aerts, T., Sachse, S.M., Vanlaer, R., Noterdaeme, L., Schmucker, D., and Seuntjens, E. (2021). Subtle roles of Down syndrome cell adhesion molecules in embryonic forebrain development and neuronal migration. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.624181"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Liu, H., Caballero-Flor\u00e1n, R.N., Hergenreder, T., Yang, T., Hull, J.M., Pan, G., Li, R., Veling, M.W., Isom, L.L., and Kwan, K.Y. (2023). DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models. PLoS Biol., 21.","DOI":"10.1371\/journal.pbio.3002078"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e70337","DOI":"10.1111\/ene.70337","article-title":"The locus coeruleus-noradrenergic system in the healthy and diseased brain: A narrative review","volume":"32","author":"Caestecker","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Alasmari, F., Ahmad, A., Alsanea, S., Hammad, A.M., and Al-Qerem, W. (2025). Current insights and prospects for the pathogenesis and treatment of clinical manifestations associated with Down syndrome through neurotransmitter, inflammatory, and oxidative stress pathways. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1592277"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","article-title":"Mouse models of Down syndrome: Gene content and consequences","volume":"27","author":"Gupta","year":"2016","journal-title":"Mamm. Genome"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Klein, J.A., and Haydar, T.F. (2022). Neurodevelopment in Down syndrome: Concordance in humans and models. Front. Cell. Neurosci., 16.","DOI":"10.3389\/fncel.2022.941855"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104717","DOI":"10.1016\/j.xpro.2026.104717","article-title":"A researcher\u2019s guide to rodent models of Down syndrome: Recent insights and translational perspectives","volume":"7","author":"Raza","year":"2026","journal-title":"STAR Protoc."},{"key":"ref_40","first-page":"117","article-title":"Segmental trisomy as a mouse model for Down syndrome","volume":"384","author":"Davisson","year":"1993","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000520925","article-title":"Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome","volume":"44","author":"Uguagliati","year":"2022","journal-title":"Dev. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.expneurol.2011.11.033","article-title":"Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome","volume":"233","author":"Best","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2017.03.009","article-title":"Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome","volume":"103","author":"Kleschevnikov","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopsych.2023.02.012","article-title":"The impact of mmu17 non-Hsa21 orthologous genes in the Ts65Dn mouse model of Down syndrome: The gold standard refuted","volume":"94","author":"Guedj","year":"2023","journal-title":"Biol. Psychiatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e56223","DOI":"10.7554\/eLife.56223","article-title":"A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21","volume":"9","author":"Kazuki","year":"2020","journal-title":"eLife"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"108379","DOI":"10.1016\/j.isci.2023.108379","article-title":"Neocortical neuronal production and maturation defects in the TcMAC21 mouse model of Down syndrome","volume":"26","author":"Kurabayashi","year":"2023","journal-title":"iScience"},{"key":"ref_47","first-page":"e0040252025","article-title":"Disrupted neurogenesis from basal intermediate precursor cells alters the postnatal neocortex in the TcMAC21 mouse model of Down syndrome","volume":"45","author":"Atak","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1203\/PDR.0b013e31819d9076","article-title":"Infantile spasms and Down syndrome: A new animal model","volume":"65","author":"Cortez","year":"2009","journal-title":"Pediatr. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Stafstrom, C.E., and Shao, L.-R. (2024). Infantile spasms in pediatric Down syndrome: Potential mechanisms driving therapeutic considerations. Children, 11.","DOI":"10.3390\/children11121513"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"dmm049721","DOI":"10.1242\/dmm.049721","article-title":"Ts66Yah, a mouse model of Down syndrome with improved construct and face validity","volume":"15","author":"Duchon","year":"2022","journal-title":"Dis. Model. Mech."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e00822","DOI":"10.1016\/j.neurot.2025.e00822","article-title":"Infantile epileptic spasms syndrome: Mechanisms and therapeutic approaches","volume":"23","author":"Stafstrom","year":"2026","journal-title":"Neurotherapeutics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/epi.16305","article-title":"The underlying etiology of infantile spasms (West syndrome): Information from the International Collaborative Infantile Spasms Study (ICISS)","volume":"60","author":"Osborne","year":"2019","journal-title":"Epilepsia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1007\/s10072-020-04600-5","article-title":"West syndrome: A comprehensive review","volume":"41","author":"Pavone","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_54","first-page":"289","article-title":"Seizures in patients with trisomy 21","volume":"7","author":"Romano","year":"1990","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1469-8749.1994.tb11894.x","article-title":"Infantile spasms in children with Down syndrome","volume":"36","author":"Stafstrom","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_56","first-page":"344","article-title":"Intellectual disability and epilepsy in Down syndrome","volume":"9","author":"Barca","year":"2014","journal-title":"Maedica"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0035-1556768","article-title":"Neurodevelopmental outcomes in children with Down syndrome and infantile spasms","volume":"13","author":"Tapp","year":"2015","journal-title":"J. Pediatr. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1528-1157.1996.tb00535.x","article-title":"Early clinical and EEG features of infantile spasms in Down syndrome","volume":"37","author":"Silva","year":"1996","journal-title":"Epilepsia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/epi4.12412","article-title":"Epileptic spasms in individuals with Down syndrome: A review of the current literature","volume":"5","author":"Kats","year":"2020","journal-title":"Epilepsia Open"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2012.09.006","article-title":"Treatment outcomes of West syndrome in infants with Down syndrome","volume":"48","author":"Sanmaneechai","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.24594","article-title":"Pediatric Epilepsy Research Consortium. Response to treatment in a prospective national infantile spasms cohort","volume":"79","author":"Knupp","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2333794X18821939","DOI":"10.1177\/2333794X18821939","article-title":"Infantile spasms in children with Down syndrome: Identification and treatment response","volume":"6","author":"Daniels","year":"2019","journal-title":"Glob. Pediatr. Health"},{"key":"ref_63","first-page":"839","article-title":"Infantile spasms and trisomy 21: Unfavorable outcomes with first-line vigabatrin therapy","volume":"48","author":"Datta","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Chen, H., Numis, A.L., Shellhaas, R.A., Mytinger, J.R., Samanta, D., Singh, R.K., Hussain, S.A., Takacs, D., Knupp, K.G., and Shao, L.R. (2025). Treatment efficacy for infantile epileptic spasms syndrome in children with trisomy 21. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1498425"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pediatrneurol.2026.01.018","article-title":"Does first-line treatment impact outcomes in trisomy 21-associated Infantile Epileptic Spasms Syndrome? A multicenter North American analysis","volume":"177","author":"Cao","year":"2026","journal-title":"Pediatr. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2023.01.004","article-title":"Biochemical mechanisms in pathogenesis of infantile epileptic spasm syndrome","volume":"105","author":"Riikonen","year":"2023","journal-title":"Seizure"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/epi.17841","article-title":"Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models?","volume":"65","author":"Ng","year":"2024","journal-title":"Epilepsia"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/epi.13034","article-title":"The GIRK2 subunit is involved in IS-like seizures induced by GABA(B) receptor agonists","volume":"56","author":"Blichowski","year":"2015","journal-title":"Epilepsia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eplepsyres.2018.06.006","article-title":"Kcnj6 (GIRK2) trisomy is not sufficient for conferring the susceptibility to infantile spasms seen in the Ts65Dn mouse model of Down syndrome","volume":"145","author":"Joshi","year":"2018","journal-title":"Epilepsy Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jnr.24985","article-title":"Envisioning the role of inwardly rectifying potassium (Kir) channel in epilepsy","volume":"100","author":"Akyuz","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.nbd.2023.106094","article-title":"Thalamocortical circuits in generalized epilepsy: Pathophysiologic mechanisms and therapeutic targets","volume":"181","author":"Lindquist","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Gutmann, N., H\u00e4ussler, U., Mersi, A., Follo, M., Bischofberger, J., and Schulz, J.M. (2026). Increased dendritic inhibition of dentate gyrus granule cells in a mouse model of Down syndrome. Front. Cell. Neurosci., 20.","DOI":"10.3389\/fncel.2026.1714586"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"115171","DOI":"10.1016\/j.expneurol.2025.115171","article-title":"Early postnatal GABAB antagonist treatment normalizes inhibitory\/excitatory balance in neonatal Ts65Dn mice, a genetic model of down syndrome","volume":"386","author":"Jin","year":"2025","journal-title":"Exp. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.yebeh.2015.10.004","article-title":"Cerebral overinhibition could be the basis for the high prevalence of epilepsy in persons with Down syndrome","volume":"53","author":"Araujo","year":"2015","journal-title":"Epilepsy Behav."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"106102","DOI":"10.1016\/j.nbd.2023.106102","article-title":"GABAergic circuits drive focal seizures","volume":"180","author":"Dossi","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Contestabile, A., Magara, S., and Cancedda, L. (2017). The GABAergic hypothesis for cognitive disabilities in Down syndrome. Front. Cell. Neurosci., 11.","DOI":"10.3389\/fncel.2017.00054"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Khalilov","year":"2012","journal-title":"Neuroscientist"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.03.005","article-title":"Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome","volume":"115","author":"Lysenko","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","article-title":"Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome","volume":"24","author":"Kleschevnikov","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Kleschevnikov, A.M. (2022). Enhanced GIRK2 channel signaling in Down syndrome: A feasible role in the development of abnormal nascent neural circuits. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.1006068"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nm.3827","article-title":"Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome","volume":"21","author":"Deidda","year":"2015","journal-title":"Nat. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.ymthe.2021.05.023","article-title":"Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome","volume":"29","author":"Parrini","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"136288","DOI":"10.1016\/j.neulet.2021.136288","article-title":"Mini-review: Synaptojanin 1 and its implications in membrane trafficking","volume":"765","author":"Choudhry","year":"2021","journal-title":"Neurosci. Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"106198","DOI":"10.1016\/j.nbd.2023.106198","article-title":"Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of Down syndrome carrying human chromosome 21","volume":"184","author":"Shao","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuroscience.2025.09.016","article-title":"Increased seizure susceptibility in TcMAC21 Down syndrome mice","volume":"585","author":"Chinnasamy","year":"2025","journal-title":"Neuroscience"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/revneuro-2019-0030","article-title":"Seizure initiation in infantile spasms vs. focal seizures: Proposed common cellular mechanisms","volume":"31","author":"Traub","year":"2020","journal-title":"Rev. Neurosci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"107686","DOI":"10.1016\/j.eplepsyres.2025.107686","article-title":"Altered synaptic functions in a humanized mouse model of down syndrome (TcMAC21): Implications for seizure susceptibility","volume":"218","author":"Shao","year":"2025","journal-title":"Epilepsy Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e12655","DOI":"10.14814\/phy2.12655","article-title":"Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome","volume":"3","author":"Cramer","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"105794","DOI":"10.1016\/j.neubiorev.2024.105794","article-title":"Intricacies of aging and Down syndrome","volume":"164","author":"Kozlov","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_92","first-page":"197","article-title":"What can we learn about Alzheimer\u2019s disease from people with Down syndrome?","volume":"69","author":"Fortea","year":"2025","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_93","first-page":"5","article-title":"Myoclonies d\u2019apparition tardive dans le syndrome de Down","volume":"1","author":"Genton","year":"1994","journal-title":"Epilepsies"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/seiz.2000.0500","article-title":"Late-onset myoclonic epilepsy in Down\u2019s syndrome (LOMEDS)","volume":"10","author":"Hamer","year":"2001","journal-title":"Seizure"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s00415-014-7376-x","article-title":"Progressive myoclonus epilepsy in Down syndrome patients with dementia","volume":"261","author":"Specchio","year":"2014","journal-title":"J. Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Altuna, M., Gimenez, S., and Fortea, J. (2021). Epilepsy in Down Syndrome: A highly prevalent comorbidity. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132776"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1684\/epd.2011.0426","article-title":"Epilepsy in adult patients with Down syndrome: A clinical-video EEG study","volume":"13","author":"Vignoli","year":"2011","journal-title":"Epileptic Disord."},{"key":"ref_98","first-page":"69","article-title":"Myoclonic epilepsy in Down syndrome and Alzheimer disease","volume":"32","author":"Salvado","year":"2017","journal-title":"Neurologia"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2012-111613","article-title":"Down syndrome and dementia: Seizures and cognitive decline","volume":"29","author":"Lott","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.seizure.2010.04.008","article-title":"Senile myoclonic epilepsy: Delineation of a common condition associated with Alzheimer\u2019s disease in Down syndrome","volume":"19","author":"Puig","year":"2010","journal-title":"Seizure"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/epi4.70277","article-title":"Progressive myoclonus epilepsy in Down syndrome with Alzheimer\u2019s disease: An 11-year longitudinal study and proposed diagnostic red flags","volume":"11","author":"Ferro","year":"2026","journal-title":"Epilepsia Open"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1528-1167.2010.02909.x","article-title":"A perfect storm: Converging paths of epilepsy and Alzheimer\u2019s dementia intersect in the hippocampal formation","volume":"52","author":"Noebels","year":"2011","journal-title":"Epilepsia"},{"key":"ref_103","first-page":"101371","article-title":"Neuronal excitation\/inhibition imbalance: Core element of a translational perspective on Alzheimer pathophysiology","volume":"69","author":"Busche","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_104","first-page":"469","article-title":"Amyloid-\u00df: A potential link between epilepsy and cognitive decline","volume":"17","author":"Romoli","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1038\/s41467-025-62798-4","article-title":"Distinct manifestations of excitatory-inhibitory imbalance associated with amyloid-\u03b2 and tau in patients with Alzheimer\u2019s disease","volume":"16","author":"Ranasinghe","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Farrell, C., Mumford, P., and Wiseman, F.K. (2022). Rodent modeling of Alzheimer\u2019s disease in Down syndrome: In vivo and ex vivo approaches. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.909669"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e71498","DOI":"10.1002\/alz.71498","article-title":"Age-related behavioral and molecular landmarks in new mouse models for studying Alzheimer\u2019s disease in Down syndrome","volume":"22","author":"Baniowska","year":"2026","journal-title":"Alzheimers Dement."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"ENEURO.0418-20.2020","DOI":"10.1523\/ENEURO.0418-20.2020","article-title":"Neuronal network excitability in Alzheimer\u2019s disease: The puzzle of similar versus divergent roles of amyloid \u03b2 and tau","volume":"8","author":"Kazim","year":"2021","journal-title":"eNeuro"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/fnl.12.8","article-title":"Alzheimer\u2019s disease and epilepsy: Insight from animal models","volume":"7","author":"Scharfman","year":"2012","journal-title":"Future Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"102844","DOI":"10.1016\/j.pneurobio.2025.102844","article-title":"Opposing interictal dynamics in Alzheimer disease and epilepsy","volume":"256","author":"Lisgaras","year":"2026","journal-title":"Prog. Neurobiol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Vicente, M., Addo-Osafo, K., and Vossel, K. (2024). Latest advances in mechanisms of epileptic activity in Alzheimer\u2019s disease and dementia with Lewy bodies. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1277613"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Tuszynski, M.H. (2025). Down syndrome: Progress in defining pathogenesis and treatments for neurodevelopmental deficits and Alzheimer\u2019s disease. Translational Neuroscience, Springer Nature Link.","DOI":"10.1007\/978-3-031-89307-0"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"113130","DOI":"10.1016\/j.isci.2025.113130","article-title":"Interferon signaling modulates Down syndrome-associated Alzheimer\u2019s disease pathology in a mouse model","volume":"28","author":"Araya","year":"2025","journal-title":"iScience"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"eadg6218","DOI":"10.1126\/sciadv.adg6218","article-title":"Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition","volume":"9","author":"Galbraith","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2174\/1570159X21666221214170234","article-title":"The JAK-STAT signaling pathway in epilepsy","volume":"21","author":"Sun","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41419-026-09035-y","article-title":"Necroptosis in Down syndrome","volume":"17","author":"Vari","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Bosco, F., Guarnieri, L., Rania, V., Palma, E., Citraro, R., Corasaniti, M.T., Leo, A., and De Sarro, G. (2023). Antiseizure medications in Alzheimer\u2019s disease from preclinical to clinical evidence. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612639"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7471\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:29:07Z","timestamp":1790483347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":118,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197471"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197471","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}